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rysms
Karan Garg, MD, Victoria Lee, BS, Caron B. Rockman, MD, Thomas S.
Maldonado, MD, Glenn R. Jacobowitz, MD, Neal S. Cayne, MD, Mark A.
Adelman, MD, Firas F. Mussa, MD, New York University LangoneMedical
Center, New York, NY
Objective(s): This study reviewed a single-institution contemporary
experience with extracranial aneurysms of the carotid artery.
Methods: Patients evaluated for an aneurysm of the extracranial ca-
rotid artery from 2005 to 2010 were reviewed. Mean follow-up was 21
months (range, 1-58 months).
Results: During the study period, 18 aneurysms were identified in 17
patients. Of these, 14 (6 men and 8 women; mean age, 62 years) underwent
surgical repair (77.8%). One pseudoaneurysm resolved on follow-up imag-
ing, and three were small for repair. The mean aneurysm size was 2.5 cm in
greatest length. One patient presented with neurologic symptoms (7.1%),
and 13 were asymptomatic. The underlying etiology was trauma in five
(35.7%), prior carotid endarterectomy in five (35.7%), and atherosclerosis in
four (28.6%). Aneurysms were isolated to the common carotid artery in six
(42.9%), internal carotid artery in five (35.7%), and the carotid bifurcation in
three (21.4%). Five patients underwent aneurysmectomy with primary re-
pair, nine underwent repair with an interposition graft, and one patient had
a plication and patch angioplasty. No deaths or neurologic events were
documented within 30 days. One patient required reintervention at 4
months for stenosis of the bypass graft, and one patient died at 10 months
from an unrelated condition.
Conclusions: Carotid artery aneurysms are uncommon and usually
asymptomatic. Prior trauma or carotid surgery were common etiologies.
The location of the aneurysms was equally distributed between the internal
and common carotid arteries. Surgical repair was safe and effective, with no
significant morbidity or mortality and good midterm stroke prevention.
Impact of Preprocedure Clopidogrel on Outcomes of Renal Angio-
plasty With or Without Stenting
Akhilesh K. Jain, MD, Albeir Y. Mousa, MD, John A. Campbell, MD, Ali F.
AbuRahma, MD, Charleston Area Medical Center, Charleston, WV
Objective(s): Restenosis remains the primary mode of failure after
technically successful endovascular reconstruction for renal artery stenosis
(RAS). Unlike in the coronary literature, the effect of clopidogrel on the
outcomes after endovascular intervention for renal artery stenosis has not
been characterized. This study was conducted to evaluate the effect of
clopidogrel on target vessel revascularization (TVR) and restenosis rates
after renal artery angioplasty with or without stenting.
Methods: This was a retrospective analysis of patients treated for RAR
in one tertiary center from January 1999 to December 2009. Patients were
divided into preadmission use of (1) clopidogrel or (2) aspirin only for the
initial procedure. TVR was defined as a tertiary procedure for symptomatic
RAS. Freedom from event (restenosis and TVR) was calculated using the
Kaplan-Meier method.
Results: A total of 88 interventions were performed on 77 patients
(66% women), with RAS. Mean age was 68.8  1.1 years, and body mass
index was 28.6 0.8 kg.m2. Comorbidities were 96% chronic hypertension,
33% diabetes, 76% hyperlipidemia, 20% renal failure, 39% tobacco use, 58%
coronary artery disease, and 51% peripheral vascular disease. Clopidogrel use
increased significantly during the initial index procedure from admission
(35.2%) to procedure (94.3%) to discharge (97.7%; both P  .001,
McNemar Test). Patients receiving clopidogrel had a decreased need for
tertiary intervention (23%) compared with aspirin (P .052). Likewise, the
cumulative rates of freedom from intervention at 8 years were 93.5% for
patients taking clopidogrel vs 61% for those taking aspirin (P  .051).
Restenosis rates did not differ between the two groups.
Conclusions: Clopidogrel tends to reduce the risk of TVR after renal
artery angioplasty and stenting. The finding however needs to be validated
by prospective studies.
Does Endovascular Repair of Ruptured Abdominal Aortic Aneurysm
Confer Survival Benefits over Open Repair?
Naveed U. Saqib, MD, Sun C. Park, MD, Taeyoung Park, PhD, Robert Y.
Rhee, MD, Rabih A. Chaer, MD, Luke K. Marone, MD, Michel S. Ma-
karoun, MD, Jae S. Cho, MD, University of Pittsburgh, Pittsburgh, Pa
Objective(s): Endovascular repair (EVAR) for ruptured abdominal
aortic aneurysm (rAAA) is being increasingly espoused despite the lack of
good-evidence for its superiority. The reported series suffer from patient and
publication selection bias and limited follow-up. This study is a single-center
propensity score comparison of early and midterm outcomes between open
repair (OR) and EVAR.
Methods: A retrospective review from January 2001 to November
2010 identified 312 patients who underwent rAAA repairs. Excluded were
31 with antecedent AAA repair and 3 with incomplete records, leaving 37
i
aVARs and 241 ORs. Propensity score-based matching for sex, age, preop-
rative hemodynamic status, surgeon’s annual AAA volume, and comorbidi-
ies was performed in 1:3 ratio to compare outcomes. We matched 37
VARs with 111 ORs. Late survival was estimated by Kaplan-Meier meth-
ds (Fig).
Results:Operative time and blood replacement were higher with OR.
verall complication rates were similar (54% EVAR vs 66% OR, P  .23),
xcept for higher incidences of tracheostomies (21% vs 3%, P  .015),
yocardial infarction (38% vs 18%, P  .036), and acute tubular necrosis
47% vs 21%, P  .009) with OR. Operative mortality rates were similar
22% EVAR vs 32% OR) with an odds ratio of 0.63 for EVAR (95%
onfidence interval, 0.24-1.48; P  .40). No differences in the incidences
or secondary interventions for aneurysm- or graft-related complications
ere noted (22% EVAR vs 22% OR, P  .99). Kaplan-Meier estimates of
urvival rates at 1, 2 and 3 years were also similar: 50%, 50%, and 42% for
VAR vs 54%, 52%, and 47% OR (P  .66).
Conclusions: EVAR for rAAA does not seem to conclusively confer
cute or late survival advantages. Routine use of EVAR for rAAA should be
eferred until prospective, randomized trial data become available.
actors Impacting Survival After Endovascular Repair of Ruptured
bdominal Aortic Aneurysms
anishMehta, MD,MPH, Sean P. Roddy,MD, Philip S.K. Paty, MD, Paul
. Kreienberg, MD, Kathleen J. Ozsvath, MD, Yaron Sternbach, MD, John
. Taggert, MD, Benjamin B. Chang, MD, R Clement Darling, III, MD,
he Vascular Group, Albany, NY
Objective(s):When compared with open surgical repair (OSR), endo-
ascular aneurysm repair (EVAR) of ruptured abdominal aortic aneurysm
rAAA) is associated with decreased morbidity and mortality. This prospec-
ive study analyzed factors that might affect the outcomes of r-AAA treated
y EVAR and OSR.
Methods: Since 2002, among 283 patients with rAAA, 157 underwent
SR (55%) and 126 underwent EVAR (45%) and grouped according to
ender, sex, and hemodynamic status at presentation. Data were prospec-
ively collected and statistical analysis was performed using 2 and life-table
ethods.
Results:Of the 283 patients with rAAA, the overall mortality was 21%
27 of 126) for EVAR vs 40% for OSR (63 of 157; P  .05). The mortality
ate of ruptured EVAR in men (1 of 90, 17%) was significantly lower than
upture EVAR in women (12 of 36, 33%), OSR in men (44 of 106, 42%),
nd OSR in women (19 of 51, 37%; P .05). The mortality rate of ruptured
VAR in patients aged 80 years (13 of 89, 15%) was significantly lower
han ruptured EVAR in patients aged80 years (14 of 37, 38%), OSR in age
80 years (15 of 43, 37%), and OSR in age 80 years (20 of 42, 48%; P 
05). In the cohort with ruptured EVAR, the mortality rate of hemodynam-
cally stable patients (10 of 84, 12%) was significantly lower than that of
emodynamically unstable patients (17 of 41, 41%; P  .05). At a mean
ollow-up of 27 months, the need for all reinterventions was similar regard-
ess of sex (29%men vs 31%women), age (25%80 years vs 23%80 years),
r patient’s hemodynamic status at the time of rAAA (26% stable vs 24%
nstable).
Conclusions: When compared with OSR, EVAR for rAAA is associ-
ted with a significant reduction in the overall mortality. This survival
dvantage of ruptured EVAR is diminished in patients who women, are aged
80 years, and are hemodynamically unstable at the time of rAAA. Furthermprovements in stent graft design and procedure techniques are needed to
ccommodate patients with these risk factors.
